1887

Abstract

The humoral immune response to flaviviruses is mainly directed to the major envelope protein, E, and a glycosylated non-structural protein, NS1. Cell-mediated immune responses, however, appear to be directed mainly against non-structural proteins. Experiments described here show that a defective recombinant adenovirus (Rad51) containing the gene encoding the NS1 protein of tick-borne encephalitis virus can induce a strong protective immune response against several pathogenic tick-borne flaviviruses in an experimental animal model, and can enhance the efficacy of conventional vaccine preparations. A protective immune response against a lethal virus challenge can also be induced by the passive transfer of antibodies, B cells or T cells from animals vaccinated with Rad51. Raised levels of non-neutralizing antibodies and cytokines associated with a T helper cell-type 1 immune response are also observed. These data demonstrate the importance of non-structural viral proteins in the protective immune response against flaviviruses and support the use of non-structural viral proteins as vaccine components.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-4-689
1998-04-01
2022-09-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/4/9568962.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-4-689&mimeType=html&fmt=ahah

References

  1. Abbas A. K., Murphy K. M., Sher A. 1996; Functional diversity of helper T lymphocytes. Nature 383:787–793
    [Google Scholar]
  2. Beutler B., Cerami A. 1989; The biology of cachectin/TNF -a primary mediator of host response. Annual Review of Immunology 7:625–655
    [Google Scholar]
  3. Bukowski J. F., Kurane I., Lai C.-J., Bray M., Falgout B., Ennis F. A. 1989; Dengue virus-specific cross-reactive CD8+ human cytotoxic T cells. Journal of Virology 63:5086–5091
    [Google Scholar]
  4. Cambell I., Greenbear T., Kochmann M. A. 1975; Macrophage reduction assay for human and mouse interferon. Canadian Journal of Microbiology 21:1247–1253
    [Google Scholar]
  5. Cardiff R. D., McCloud T. G., Russell P. K. 1970; Molecular size and charge relationships of the soluble complement-fixing antigens of dengue virus. Virology 41:569–572
    [Google Scholar]
  6. Chambers T. J., Hahn C. S., Galler R., Rice C. M. 1990; Flavivirus genome organisation, expression and replication. Annual Review of Microbiology 44:649–688
    [Google Scholar]
  7. Coffman R. L., Lebman D. A., Rothman P. 1993; Mechanisms and regulation of immunoglobulin isotype switching. Advances in Immunology 54:229–270
    [Google Scholar]
  8. Dzhivanyan T. I., Korolev M. V., Karganova G. G., Lisak V. M., Kashyanova G. M., Chuprinskaya M. V. 1988; Changes in host-dependent characteristics of tick-borne encephalitis virus upon its adaptation to ticks and re-adaptation to white mice. Voprosi Virusologii 5:589–595
    [Google Scholar]
  9. Falker W. A. Jr Diwan A. R., Halstead S. B. 1973; Human antibody to dengue soluble-complement fixing (SCF) antigens. Journal of Immunology 111:1804–1809
    [Google Scholar]
  10. Fooks A. R., Schadeck E., Leibert U. G., Dowsett A. B., Rima B. K., Steward M. W., Stephenson J. R., Wilkinson G. W. G. 1995; High level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-I-restricted CTL response and protection in a murine model. Virology 210:456–465
    [Google Scholar]
  11. Gould E. A., Buckley A., Barrett A. D. T., Cammack N. 1986; Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67:591–595
    [Google Scholar]
  12. Graham F. L., Prevec L. 1992; Adenovirus-based expression vectors and recombinant vaccine. In Biotechnology 20 Vaccines, New Approaches to Immunological Problems pp. 363–390 Ellis R. W. Edited by Boston: Butterworth-Heinemann;
    [Google Scholar]
  13. Hall R. A., Brand T. N. H., Lobigs H., Sangster M. Y., Howard M. J., Mackenzie J. S. 1996; Protective immune response to the E and NSl proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice. Journal of General Virology 77:1287–1294
    [Google Scholar]
  14. Halstead S. B. 1979; In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. Journal of Infectious Diseases 140:527–533
    [Google Scholar]
  15. Halstead S. B. 1982; Immune enhancement of viral infection. Progress in Allergy 31:301–364
    [Google Scholar]
  16. Hambleton P., Stephenson J. R., Baskerville A., Wiblin C. N. 1983; Pathog enesis and immune response of vaccinated and unvaccinated rhesus monkeys to TBEV. Infection and Immunity 40:995–1003
    [Google Scholar]
  17. Henry C. 1980; Cell separation. In Selected Methods in Cellular Immunology pp. 182–194 Michal S. F. B. Edited by Location of publisher: Freeman Corporation;
    [Google Scholar]
  18. Holzmann H., Vorobyova M. S., Lodyzhenskaya I. R., Ferenci K., Kundi M., Kunz C., Heinz F. X. 1992; Molecular epidemiology of tick-borne encephalitis virus : cross-protection between European and Far-eastern subtypes. Vaccine 10:345–349
    [Google Scholar]
  19. Jacobs S. C., Wilkinson G. W. G., Stephenson J. R. 1992; High level expression of TBEV NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. Journal of Virology 66:2086–2095
    [Google Scholar]
  20. Jacobs S. C., Stephenson J. R., Wilkinson G. W. G. 1993; Sequence of the NS1 protein gene of the K23 isolate of TBEV and identification of conserved motifs. Archives of Virology 129:279–285
    [Google Scholar]
  21. Jacobs S. C., Stephenson J. R., Wilkinson G. W. G. 1994; Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. Journal of General Virology 75:2399–2402
    [Google Scholar]
  22. Kaufmann S. H. E. 1993; Immunity to intracellular bacteria. Annual Review of Immunology 11:129–163
    [Google Scholar]
  23. Klockmann U., Krivanec K., Stephenson J. R., Hilfenhaus J. 1991; Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine. Vaccine 9:210–212
    [Google Scholar]
  24. Krasilnikov I. V., Elbert L. B., Khanina M. K., Sobolev S. G. 1984; Comparative study of infectious and formaldehyde-inactivated tick-borne encephalitis virus particles. Archives of Virology 79:241–253
    [Google Scholar]
  25. Kurane I., Meager A., Ennis F. A. 1989; Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production and cytotoxic activity. Journal of Experimental Medicine 170:763–775
    [Google Scholar]
  26. Kurane I., Brinton M. A., Samson A. L., Ennis F. A. 1991; Dengue virus-specific, human CD4+ CD8 cytotoxic T cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. Journal of Virology 65:1825–1828
    [Google Scholar]
  27. Lobigs M., Arthur C. E., Muellbacher A., Blanden R. V. 1994; The flavivirus non-structural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology 202:195–201
    [Google Scholar]
  28. Parrish C. L., Coa G., Hill A., Muellbacher A., Westaway E. G., Blanden R. V. 1991; Preliminary analysis of murine cytotoxic T cell responses to the proteins of the flavivirus Kunjin using vaccinia virus expression. Journal of General Virology 72:1645–1653
    [Google Scholar]
  29. Peiris J. S. M., Porterfield J. S. 1982; Antibody-dependent enhancement : its antigenic specificity in relation to Togaviridae. Journal of General Virology 58:291–296
    [Google Scholar]
  30. Phillpotts R. J., Stephenson J. R., Porterfield J. S. 1985; Antibody-dependent enhancement of tick-borne encephalitis virus infectivity. Journal of General Virology 66:1831–1837
    [Google Scholar]
  31. Reed L. J., Muench H. 1938; A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
  32. Robbins D. S., Shirazi Y., Drysdale B. E., Lieberman A., Shin H. S., Shin M. L. 1987; Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. Journal of Immunology 139:2593–2597
    [Google Scholar]
  33. Rothman A. L., Kurane I., Lai C.-J., Bray M., Falgout B., Men R., Ennis F. A. 1993; Dengue virus protein recognition by virus-specific murine CD 8+ cytotoxic lymphocytes. Journal of Virology 67:801–806
    [Google Scholar]
  34. Rubin R. A., Rourke L. B. 1994; Adenovirus vaccines. In Vaccines, 2nd edn. pp. 475–501 Plotkin S. A., Mortimer E. A. Edited by Philadelphia: Saunders;
    [Google Scholar]
  35. Ruff M. R., Gifford G. I. 1981; Tumor necrosis factor. In Lymphokines II pp. 235–272 Pick I. Edited by New York: Academic Press;
    [Google Scholar]
  36. Schlesinger J. J., Brandiss M. W., Walsh E. E. 1985; Protection against yellow fever 17D encephalitis in mice by passive transfer of monoclonal antibodies to the non-structural glycoprotein gp48 and by active immunization with gp48. Journal of Immunology 135:2805–2809
    [Google Scholar]
  37. Schlesinger J. J., Brandriss M. W., Cropp C. B., Monath T. P. 1986; Protection against yellow fever in monkeys by immunization with yellow fever non-structural protein 1. Virology 60:1153–1155
    [Google Scholar]
  38. Schwartz A. R., Togo Y., Hornick R. B. 1974; Clinical evaluation of live, oral types 1, 2 and 5 adenovirus vaccines. American Review of Respiratory Disease 109:233–238
    [Google Scholar]
  39. Spies J. M., Westland K. W., Bonner J. G., Pollard J. D. 1995; Intraneural activated T-cells cause focal break-down of the blood-nerve barrier. Brain 118:857–868
    [Google Scholar]
  40. Stephenson J. R. 1988; Flavivirus vaccines. Vaccine 6:471–480
    [Google Scholar]
  41. Stephenson J. R., Wilton-Smith P., Lee J. M. 1984; Antigenic variation among members of the tick-borne encephalitis complex. Journal of General Virology 65:81–89
    [Google Scholar]
  42. Venugopal K., Buckley A., Reid H. W., Gould E. A. 1992; Nucleotide sequence of the envelope glycoprotein of Negishi virus shows very close homology to louping ill virus. Virology 190:515–521
    [Google Scholar]
  43. Warnes A., Walkland A., Stephenson J. R. 1986; Development of an ELISA assay for staphylococcal protein A produced in E. coli by pUC8 based plasmids containing the S. aureus Cowan 1 protein A gene. Journal of Immunological Methods 93:63–70
    [Google Scholar]
  44. Wilkinson G. W. G., Akrigg A. 1992; Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Research 20:2233–2239
    [Google Scholar]
  45. Wilkinson G. W. G., Borysiewicz L. K. 1995; Gene therapy and viral vaccination: the interface. British Medical Bulletin 51:205–216
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-4-689
Loading
/content/journal/jgv/10.1099/0022-1317-79-4-689
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error